Impact of molecular subtypes on the prediction of distant recurrence in estrogen receptor (ER) positive, human epidermal growth factor receptor 2 (HER2) negative breast cancer upon five years of endocrine therapy

Table 4 Cox regression and log rank analysis: Luminal A-like vs. other subtypes

		Hazard Ratio			Log-Rank Test
Effect	Subset	Estimate	95% CIs	p-value	p-value
Luminal A-like vs. other subtypes	all patients	0.350	0.16–0.76	0.0078	0.0053
	0–3 positive nodes	0.370	0.16–0.85	0.0184	0.0141
	node negative	0.344	0.14–0.86	0.0234	0.0177
Luminal-A-like vs. Luminal B-like	all patients	0.37	0.19–0.81	0.0141	0.0106

ISSN: 1471-2407